Nu Skin
Sells beauty, wellness, and ageLOC device products through social direct selling.
Something off on this page? Send us feedback.
Profile
Sells beauty, wellness, and ageLOC device lines through person-to-person and digital channels, with Rhyz adding manufacturing and investment operations. Revenue is mostly international and depends on sales-leader productivity, direct-selling rules, and ongoing Mainland China regulation.
Beauty and wellness lines include Nu Skin skin care, Pharmanex nutrition, Nutricentials, Beauty Focus, and ageLOC devices and supplements. Products are sold through direct selling, person-to-person marketing, and digital or social platforms rather than mass retail.
Operations are spread across the Americas, Asia, Europe, Africa, and Rhyz manufacturing businesses, with most revenue generated outside the United States. Rhyz adds owned manufacturing and investment capabilities that support supply-chain control, speed to market, and product development.
The model depends on active Sales Leaders, product launches that keep the channel engaged, and compliance with direct-selling rules. Mainland China remains a distinct regulatory dependency because its market uses licensed structures, sales employees, and independent marketers.
Company facts
Key statistics
Year to date −50.1% · Average volume (30d) 548.6K
Analysts
Ratings
Target range
Latest analyst notes
No analyst notes in the last 24 months.
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 10, 2026Q2 FY26 | $0.20 | $0.20 | 0.0% | $345.2M | $320.1M | −7.3% | −5.44% |
| Aug 9, 2026Q2 FY26 | $0.20 | $0.20 | 0.0% | $345.2M | $320.1M | −7.3% | −6.19% |
| May 7, 2026Q1 FY26 | $0.15 | $0.14 | −6.7% | $329.7M | $320.6M | −2.8% | +1.99% |
| Feb 12, 2026Q4 FY25 | $0.30 | $0.29 | −3.3% | $382.7M | $370.3M | −3.2% | −18.12% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $364.5M | $386.1M | $364.2M | $370.3M | $320.6M | $320.1M | |
| Gross profit | $247.0M | $265.7M | $256.7M | $262.0M | $214.5M | $218.3M | |
| Operating income | −$9.9M | $30.8M | $21.6M | $23.2M | $5.9M | −$59.3M | |
| Net income | $107.5M | $21.1M | $17.1M | $14.5M | $1.8M | −$249.8M | |
| Diluted EPS | $2.14 | $0.43 | $0.34 | $0.29 | $0.04 | −$5.14 | |
| Gross margin | 67.8% | 68.8% | 70.5% | 70.7% | 66.9% | 68.2% | |
| Operating margin | -2.7% | 8.0% | 5.9% | 6.3% | 1.8% | -18.5% |
Fiscal years (4-quarter sums)FY21 $2.70B · FY22 $2.23B · FY23 $1.97B · FY24 $1.73B · FY25 $1.49B
Revenue by product · Q4 FY25
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $189.6M · Total debt $263.7M · Total assets $1.12B · Shareholders' equity $542.7M
Dividends
Last cut to $0.06 from $0.39 in Feb 2024. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 28, 2026 | Aug 28 | Sep 9 | $0.06 | |
| May 29, 2026 | May 29 | Jun 10 | $0.06 | |
| Feb 27, 2026 | Feb 27 | Mar 11 | $0.06 | |
| Nov 28, 2025 | Nov 28 | Dec 10 | $0.06 | |
| Aug 29, 2025 | Aug 29 | Sep 10 | $0.06 | |
| May 30, 2025 | May 30 | Jun 11 | $0.06 | |
| Feb 24, 2025 | Feb 24 | Mar 5 | $0.06 | |
| Nov 29, 2024 | Nov 29 | Dec 11 | $0.06 |
Ownership
Shares outstanding 48.55M · Float 47.14M · 97.1% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.32M | 8.89% | 13F | Aug 7, 2026 |
| American Century Companies Inc | 2.30M | 4.74% | 13F | Aug 12, 2026 |
| Vanguard Capital Management LLC | 2.05M | 4.22% | 13F | Aug 13, 2026 |
| Acadian Asset Management LLC | 1.95M | 4.02% | 13F | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 1.80M | 3.70% | 13F | Aug 11, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 11, 2026 | Laura Nathanson | director | −2,676 | $6.73 |
| Nov 11, 2025 | Steven Keith Hatchett | officer: Chief Product Officer | +5,500 | $9.61 |
| Sep 3, 2025 | Chayce David Clark | officer: EVP and General Counsel | −20,000 | $11.97 |
| Sep 4, 2025 | Laura Nathanson | director | −6,489 | $12.22 |
| Aug 29, 2025 | Daniel W. Campbell | director | −32,437 | $12.11 |
Peers
- Herbalife
Direct-selling nutrition rival with global distributor overlap
- USANA Health Sciences
Direct-selling wellness peer in supplements and skincare
- Estée Lauder Companies
Prestige beauty leader contesting skincare and anti-aging spend
- Coty
Prestige and mass beauty peer across fragrance, color and skincare
- e.l.f. Beauty
Fast-growing masstige beauty rival in cosmetics and skincare
- LifeVantage
Direct-selling supplements and personal-care peer
- Medifast
Coach-guided weight-management peer in nutrition and wellness
- Oddity Tech
Digital-first beauty and wellness challenger
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Nu Skin | $4.85 | +0.21% | $235.5M | — | 5.0 | 0.2 | −17.1% |
| Herbalife | $12.50 | +0.52% | $1.29B | 8.0 | 4.7 | 0.2 | +5.4% |
| USANA Health Sciences | $14.04 | +0.07% | $259.2M | — | 13.8 | 0.3 | −5.3% |
| Estée Lauder Companies | $103.41 | +0.01% | $37.39B | 206.8 | 31.2 | 2.5 | +6.5% |
| Coty | $2.86 | +0.18% | $2.51B | — | 9.0 | 0.4 | +1.3% |
| e.l.f. Beauty | $104.44 | +0.33% | $6.14B | 104.1 | 33.7 | 3.5 | +35.5% |
| LifeVantage | $6.26 | −1.11% | $80.2M | 15.9 | 17.3 | 0.4 | −23.1% |
| Medifast | $12.18 | +0.16% | $135.4M | — | — | 0.4 | −27.6% |
| Oddity Tech | $14.20 | −0.98% | $817.9M | 18.3 | 28.9 | 1.1 | −26.2% |
| Median | 18.3 | 17.3 | 0.4 | −2.0% |